In Asia Pacific’s fast-evolving landscape, we see unique opportunities to synergize our existing successes. Effective 3 October 2022, I have the immense honour and pleasure to announce the official integration of FUJIFILM Asia Pacific’s Medical Product Business into FUJIFILM Healthcare Asia Pacific (HCAP).
This marks the exciting and historic beginning of a new HCAP. With solidified technological prowess and accelerated drive for innovation, the combined company can now offer a comprehensive line-up of one-stop solution, scaling up growth of FUJIFILM Healthcare business.
Integrating FUJIFILM’s proprietary image-processing and AI technology with the new range of robust imaging modalities, supported by a strong service support system, and dedicated training and education programs, we are confident in bridging the gap for our customers, to enter the future of healthcare.
As the saying goes, teamwork is truly the key to our success. HCAP will continue to accelerate the synergy within global subsidiaries and local channel partners to respond swifty and flexibly to market changes. Uniting a great team of enthusiastic learners and effective collaborators, we will move forward as One FUJIFILM, and NEVER STOP creating new solutions to contribute to better health and quality of life.
Managing Director
Noriyuki Kawakubo